Because bone marrow (BM) transplantation is used with increasing frequency, it is important t o elucidate the mechanisms involved in the establishment of tolerance t o host minor histocompatibility antigens (MIHA) in recipients transplanted with T-cell-undepleted marrow grafts. We have previously shown that BM chimeras transplanted across MiHA barriers showed specific unresponsiveness t o MiHA expressed on recipient-type concanavalin A blasts. Because expression of many MiHA is tissue-specific, we wanted t o determine if chimera T lymphocytes would be tolerant t o MiHA expressed by all host tissues and organs. To investigate this issue, we measured in vivo proliferation of lymphoid cells from normal C57BL/10 (B101 mice and (B10 + LP) chimeras in tissues and organs of lethally irradiated syngeneic and allogeneic recipients. Donor B10 cells were LTHOUGH bone marrow transplantation (BMT) is being used with increasing frequency, particularly for treatment of malignant hematologic disorders, graft-versus-host disease (GVHD) still represents a major barrier and, despite intensive research, little progress has been accomplished during the last few years.' Thus, T-cell depletion, the most straightforward approach to prevent GVHD, has proved unsatisfactory because it is associated with increased rates of graft rejection and leukemic relapse.' Clinical and experimental observations have shown that graft-host tolerance could sometimes be obtained after BMT across minor histocompatibility antigen (MiHA) barriers but the mechanisms involved were poorly defined and the occurrence of GVHD remained unpredictable, because it was observed in some but not all donorhecipient corn bin at ion^.^.^
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The development of graft-host tolerance in BM chimeras reconstituted with T-lymphocyte-undepleted hematopoietic cells is probably more demanding than the acquisition of self-tolerance because both mature T cells and immature thymocytes encounter host antigen. The most controversial issue relates to the involvement of peripheral (extrathymic) mechanisms in this process.' On the one hand studies with transgenic mice suggest that expression of histocompatibility antigen on peripheral epithelial cells can induce tolerance by deletion or inactivation.'"' On the other hand, recent studies by Sprent et all2 challenged this view. Indeed, tolerance was not apparent when thymectomized parent -+ F1 chimeras were given parental strain thymus grafts.12 This last experiment suggests that the expression of host H-2 antigen in the extrathymic environment of chimeras is not tolerogenic for mature T cells.
We have developed a model in which C57BL/6J (B6) or C57BWlOSnJ (B10) BM cells were transplanted in lethally irradiated LP/J (LP) recipients to investigate the mechanisms responsible for tolerance to host MiHA.4.5.13 Although addition of 1 to 5 X lo7 spleen cells (as a source of T lymphocytes) to the BM inoculum provoked a rapidly lethal GVHD, transplantation with only lo7 unmanipulated B6 or B10 BM cells (containing 2 to 3 X lo5 T cells) yielded healthy (B6"LP) or (B 1WLP) chimeras, Recipient mice were complete donor-type chimeras with no signs of graft rejection, either untreated, or depleted with anti-Thy-1.2, anti-CD4, or anti-CD8 antibodies. Transplantation of B10 cells in LP recipients triggered an important T-cell-dependent '*'I-dUrd uptake in several organs that involved both CD4+ and CD8+ cells. Using Thy-l -congeneic mice we showed that in longterm chimeras pratically all CD4+ and CD8+ T lymphocytes were derived from hematopoietic progenitors and not from mature T cells present in the BM graft. When (B10 + LP) BM chimera cells were injected t o secondary recipients, no proliferation was obsewed in any organ of LP hosts whereas normal proliferation was seen in H-2' allogeneic hosts. Thus, in these BM chimeras, tolerance encompasses MiHA expressed by all organs. mixed chimerism or GVHD.4*5 They had a normal survival rate and showed excellent immune reconstitution. Detailed studies of (B10 -+ LP) chimera cytotoxic T-lymphocyte (CTL) responses to single or multiple MiHA showed that they were specifically unresponsive to host(LP)-and donor(B10)-type MiHA but showed normal responses to thirdparty MiHA. l4 However, these studies were only informative with regard to MiHA expressed on T lymphoblast cells, ie, concanavalin A (Con A) blast targets used for in vitro experiments. Because nonhematopoietic cells are the critical targets of GVH and expression of most MiHA appears to be tissue-specific and not u b i q~i t o u s , '~'~~ it was important to determine whether grafted T cells became tolerant to MiHA expressed by all tissues and organs. Therefore, using I2'I-dUrd incorporation assay, we evaluated in situ proliferative response of grafted cells from B10 or (B10 -+ LP) chimera donors in several host tissues and organs after their injection to lethally irradiated B10, LP, or third-party recipients.
Our results showed that disparity for multiple MiHA induced marked in vivo proliferation of transferred T cells that could be detected and measured in most lymphoid and nonlymphoid organs. More importantly, we showed that (B10 -+ LP) chimera T cells were fully tolerant to host (LP) MiHA expressed on various nonhematopoietic organs.
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BROCHU ET AL C57BLIIOSnJ (Mlsb), B6.PL-Thy-lNCy (B6-Thy-1.1). LP/J (MW), C3H.SWISnJ (MIS'), 1291J (MIS uncharacterized), and A.BY/SnJ (MW). They are mutually unresponsive in primary mixed lymphocyte reaction because H-2' is a nonstimulatory haplotype in the recognition of Mls'.'' Two strains of H-2k mice were also used: B1O.BWSgSnJ (Mlsb) and C3WHeJ (MW). Adult male mice were purchased from the Jackson Laboratory (Bar Harbor, ME) and housed in a conventional facility. Irradiated (9.5 Cy) LP or B10 mice injected with lo7 unmanipulated B10 BM cells are referred to as (B10 -* LP) and (B10 + B10) chimeras, respectively. We used these chimeras as source of donor cells 100 to 150 days posttransplant because we had previously shown that chimeras were immunocompetent at that time? All chimeras were between 20 and 30 weeks of age when studied. Other mice used as cell donor and/or irradiated recipients were between 6 and 16 weeks of age.
Origin of CD4+ and CD&' + T cells in BM chimeras. Standard BM chimeras. described in the preceding paragraph, were reconstituted with IO' BM cells containing 2. Axillary and cervical LN from B6-Thy-l. 1 or B6 mice were collected, teased apart, and washed. BM collected from B6 or B6-Thy-1.1 donors was T cell depleted with specific anti-Thy- Cell transplantation and GVHD induction. Mice were transplanted as described previously? Briefly, recipient mice received 9.5 Cy total body irradiation from a source at a dose rate of 128 cGylmin 6 to 18 hours before their reconstitution with an inoculum of hematopoietic cells (2.5 X lo7 spleen cells mixed with lo' BM cells). Spleen and BM cells, obtained from the tibiae and femurs, were administered as a single intravenous injection, via the tail vein, in a volume of 0.5 mL of serum-free RPM1 1640 media. Under these conditions all types of H-2' recipients grafted with untreated B10 cells die of severe GVHD."
Measure of grafted cell proliferative activity. We measured in vivo proliferation of grafted cells (Fig 1) in several host tissues and organs using a method originally developed by Spach and M~t t a . '~ Briefly, on day 6 (H-2k mice) or on day 8 (H-2' mice) after irradiation and cell transplantation, mice received an intraperitoneal (ip) injection of fluoro-2-dUrd mol in 0.1 mL saline) followed I hour later by an ip injection of '"I-dUrd (1.5 pCi in 0.1 mL). Incorporation of '"I-dUrd is lowered by competition with endogenous thymidine. The use of fluoro-2-dUrd, which acts as an inhibitor of thymi- dine synthesis, decreases this competition. One hour after labeling, mice were anesthetized for cardiac puncture and then killed by cervical dislocation. Twenty-one organs were excised, cleansed, and weighed. In the case of skin and muscle, each sample consisted of 100 mg of tissue. Individual organs were repetitively soaked in 70% ethanol and the DNA-bound radioactivity measured in a gamma counter. Results, corrected for isotope decay and background, were expressed either as cpndorgan, or in the form of an allogeneic/ syngeneic ( A / S ) ratio calculated with the following formula: AIS ratio = mean cpm in allogeneic recipientlmean cpm in syngeneic B10 recipient. An A / S ratio 2 3 was considered positive. Results observed in various types of allogeneic recipients are depicted as vertical bars in Figs 2 through 6 and those observed in syngeneic controls as a clear horizontal area in Fig 2. Depletion of Thy-l+, CD4', and CD8' cells. Cells to be treated were resuspended at a concentration of 1 X IO' cells/mL and incubated with depleting MoAb at 4°C for 1 hour. They were then pelleted by centrifugation, resuspended in rabbit serum as a source of complement, and incubated at 37°C for 1 hour. Cell suspensions were washed three times, analyzed for efficacy of depletion by direct cytometry, and then adjusted for injection. For proliferative activity assays, spleen and BM B 10 cells were depleted separately and mixed in adequate concentration just before injection. To keep constant the number of non-T cells in each inoculum, the total quantity of spleen cells (2.5 X lo7 in recipients of unmanipulated graft) injected to recipients of Thy-1.2-, CD-4-and CD-8-depleted grafts was adjusted to 1.7 X IO7, 2.07 X IO7, and 2.2 X IO7, respectively.
Immunofluorescence staining and ~uorescence-activated cell sorter (FACS) analysis. Single-and double-immunofluorescence staining were performed drectly with FITC and PE-conjugated MoAbs. Five hundred thousand cells per sample were incubated for 25 minutes at 4°C with the appropriate FITC-and/or PE-conjugated MoAbs (double labeling analysis) diluted in a final volume of 125 pL PBS. After 3 washes in PBS, propidium-iodine negative cells were analyzed for surface fluorescence on a FACStar plus flow cytometer (Becton Dickinson) and the data were processed using the Lysys I1 program (Becton Dickinson). Nonspecific binding of 
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MoAbs was also assessed by labeling cells with FITC-and/or PEconjugated isotype-matched controls.
RESULTS
Proliferative activity of grafted cells from B10 donors.
I-dUrd incorporation in syngeneic B 10 recipients showed major differences among the 21 organs tested as it ranged from 10' to lo5 cpdorgan. Similar results were obtained in six experiments (Fig 2) . When '251-dUrd uptake was measured in allogeneic LP recipients and compared with syngeneic recipients, three patterns were observed. In most organs (thereafter referred to as type l), Iz51-dUrd uptake was greater in allogeneic than in syngeneic recipients: testes, heart, lungs, kidneys, pancreas, liver, muscles, slun, esophagus, and LN. In type 2 organs (BM, spleen, and gastrointestinal tract [GIT]) no allogeneiclsyngeneic difference was detected. The thymus was the sole organ where incorporation was lower in allogeneic than in syngeneic recipients (type 3). T-cell depletion of B 10 inoculum before injection to irradiated LP recipients decreased '"I-dUrd uptake in type 1 organs down to levels observed in syngeneic hosts, but did not influence incorporation in type 2 organs. T-cell-indepen-500 n -. For personal use only. on October 23, 2017. by guest www.bloodjournal.org From dent uptake in type 2 organs could be ascribed to two mechanisms. "'I-dUrd incorporation in hematopoietic organs (BM, spleen) was abrogated in irradiated ungrafted LP recipients and therefore resulted from the proliferation of donor-derived hematopoietic cells. On the other hand, high uptake in the GIT was independent of donor cells since it was observed in irradiated unreconstituted hosts. High GIT uptake may be caused by repair from the radiation induced damage or to incorporation by intestinal and gastric glandular secretion^.^^ When B 10 hematopoietic cells were injected to three other types of MiHA-incompatible H-2b recipients (C3H.SW, 129, and A.BY), organ-specific '"I-dUrd uptake showed some strain to strain variations but the same three patterns were observed (Fig 3) . Thus, recognition of allogeneic MiHA induced a significant T cell, or at least T-dependent, proliferation in LN and a large variety of nonhematopoietic organs in the four types of H-2b recipients. High T-cell-independent '*'I-dUrd uptake precluded evaluation of T-cell responses in type 2 organs.
Role of T-cell subsets. The effect of in vitro depletion of CD4' or CD8' lymphocytes on ?-dUrd uptake by type l organs was evaluated in irradiated LP recipients grafted with B10 hematopoietic cells (Fig 4) . Depletion of both CD4' and CD8+ lymphocytes decreased, to a variable extent, proliferative activity in 9 to IO of 12 organs tested. CDCdepletion had a greater impact on some organs but the reverse was true for others. Similar results were obtained in 129 recipients but a different organ pattern was observed (data not shown).
Proliferation of transplanted (B10 -+ LP) chimera cells. After transplantation of (B 10 "* LP) chimera cells into irradiated B10 recipients, the tissue-specific pattern of "'I-dUrd incorporation was similar to the one obtained with normal B10 donors (data not shown). However, results were strikingly different when chimera cells were transplanted in secondary LP recipients (Fig 5 ) . Contrary to what was observed in recipients of B10 cells, no T-cell-dependent proliferation was seen in any type 1 organ of LP mice transplanted with chimera cells (ie, NS ratio < 3). The pattern of Iz5I-dUrd incorporation was similar to the one observed after syngeneic transplantation or T-depleted allogeneic transplantation. Thus, in vivo, (B10 . + LP) chimera cells were totally unresponsive to MiHA expressed on all tissues from LP mice.
When (B 10 . + LP) chimera hematopoietic cells were transplanted in third-party recipients such as C3H.SW, 129, and A.BY, T-cell-specific proliferation in type 1 organs was much lower than what was measured in recipients of B10 cells (compare Figs 3 and 5) . T-cell-dependent uptake was completely abrogated in some organs and significantly decreased in others. Although we had shown with a number of in vivo and in vitro tests that our 100-day-old BM chimeras were immunocompetent: in healthy BM patients some T-cell responses take up to four years to normalizez5 To determine if hematopoietic (B10 "* LP) chimera cells have the capacity to generate a normal proliferative response in vivo, they were transplanted into irradiated major histocompatibility complex (MHC)-incompatible recipients with or without minor lymphocyte stimulating loci (Mls) difference (Fig 6) . The proliferation of (B10 -+ LP) chimera cells in type 1 organs was normal when compared with that of (B10 -+ B10) chimera and B10 donor cells. The pattern of '251-dUrd incorporation showed the same level of uptake in all organs. Thus, although responsiveness of chimera cells to third-party MiHA was significantly depressed, their responsiveness to MHC antigens was normal.
Origin of T cells in (B10 -+ LP) BM chimeras. After observation that cells from long-term BM chimeras were tolerant to all MiHA expressed by host cells, we questioned the origin of their T lymphocytes. Do they derive from maturation of hematopoietic progenitors or from expansion of mature T cells present in the original BM inoculum? Table  1 shows the results of two sets of experiments using a combination of Thy-l -congeneic hematopoietic progenitors (Tdepleted BM cells) and mature T cells (LN cells). Phenotyping with anti-Thy-1.1 and anti-Thy-1.2 MoAbs showed that all thymic cells were derived from hematopoietic progenitors. In the spleen, 92% to 96% of the CD4' and 78% to 88% of the CD8' T lymphocytes were also derived from hematopoietic progenitors whereas a minority had the same phenotype as LN cells present in grafted cells.
DISCUSSION
The first evidence that "in vivo mixed lymphocyte reaction" could detect MiHA incompatibilities was provided some years ago by Spach and Motd' in a strongly MIS stimulatory H-2d strain combination: (B 10.D2 X DBN2)Fl (Mlsb x Mlsd) recipients were reconstituted with B10.D2 (Mlsb) hematopoietic cells. At this time, MIS superantigens were confused with MiHA under the imprecise denomination of "non-MHC antigen." The present studies confirm and expand these original observations by showing that disparity for multiple MiHA can induce significant and measurable in situ proliferation of transplanted T cells in Mls nonstimulatory donorhecipient combinations. We detected T-cell proliferation in all extrathymic lymphoid and nonlymphoid organs, except for the GIT and hematopoietic organs (BM, spleen) where the high basal "'I-dUrd uptake precluded further evaluation. This is consistent with histologic description of tissues obtained 7 to 8 days after BMT across various types of MiHA barriers showing widespread lymphocytic infiltrates in the skin, liver, pancreas, lungs, and kid-
The thymus was an exception because we observed a decreased T-cell-dependent 1z51-dUrd uptake in allogeneic recipients compared with syngeneic recipients. We hypothesized that maturation in an MiHA-incompatible thymus may possibly increase negative selection by causing deletion of T-cell clones recognizing both donor-and hosttype MiHA expressed on hematopoietic antigen-presenting cells and epithelial cells, respectively. However, this hypothesis remains highly speculative.
Our depletion experiments with anti-CD4 and anti-CD8 MoAbs provided evidence that both T-cell subsets responded to allogeneic MiHA after BMT. The relative contribution of each lymphocyte subset showed significant variation among various organs. This is consistent with a number of observations: firstly, MiHA peptides are associated with both MHC class I and class I1 molecules'7~28; secondly, both CD4' and CD8' T cells can contribute to anti-MiHA GVHD".'": and thirdly, both subsets have significant proliferative potential.3'
The aim of the present work was to characterize the state neys,15.2h.27
For personal use only. of tolerance to host MiHA in lethally irradiated BM chimeras reconstituted with T-cell-undepleted graft. Specifically, we wanted to determine if (B10 -+ LP) chimeras' T cells would be unresponsive to MiHA expressed on all tissues of the LP host. Our analysis of '251-dUrd incorporation in tissues and organs of secondary LP recipients injected with chimeras' T cells clearly showed that the latter did not proliferate in any organ. This is consistent with previous observations that chimera cells cannot trigger GVH reaction when injected into secondary LP recipients4 and are unresponsive to host MiHA when tested in CTL assays against LP Con A blast targets.I4 Thus, according to both in vitro CTL assays'4 and in vivo proliferation studies (Fig 5) , BM chimeras are tolerant to MiHA expressed by all organs of the host. Although the number of MiHA gene differences between various inbred strains of mice is probably greater than 403' and the product of many of these can probably stimulate in vivo T-cell pr~liferation,~~ we must remember that T-cell response to MiHA is characterized by the phenomenon of immun~dominance.~~~~' When an animal is immunized with cells from an MHC-identical animal presenting multiple incompatible MiHA loci, T-cell responses are directed against only a few "dominating" MiHA whereas many MiHA are neglected or "dominated." Therefore, strictly speaking, the conclusion of the preceding paragraph applies to MiHA that are immunodominant in our model and not necessarily to the product of all MiHA genes.
Proliferation of chimera T cells in H-2b third-party recipients (A.BY, C3H.SW, 129) showed a significant depression (Fig 5) that did not seem to involve immune deficiency because chimera T cells' proliferation in MHC-allogeneic hosts was similar to that of normal B10 lymphocytes. A priori, this depression was not expected because chimera cells responded normally to third party MiHA in CTL assays against Con A blast targets.14 Such a state of in vivo but not in vitro unresponsiveness is frequently called "split tolerance." It is thought to reflect the fact that tolerance induction is a multi-step process that may occur in a step-wise fashAfter their first encounter with antigen, T cells may be functionally inactivated but not physically deleted. Anergized T-cells, may persist indefinitely or may be eliminated after subsequent encounters with antigen. The conditions used for CTL assays, ie, in vivo priming followed by in vitro restimulation, may show the presence of anergizedundeleted T cells.
Knowing that (B10 -+ LP) T cells were tolerant to host MiHA, we wondered if they were derived from mature T cells present in the BM graft, implying that the tolerance state depended on peripheral mechanisms. On the contrary, we found that around day 65 postreconstitution most lymphocytes (about 94% of the CD4' and 83% of the CD8' T cells) originated from BM progenitors and thus, had an opportunity to get thymic education in the LP host. Our previous work suggested that peripheral tolerizing cells were 
